Stroke

Results of HOME-PE suggest an approach using HESTIA was noninferior to sPESI for patients with acute pulmonary embolism.

A pair of studies provides an overview of declines in use of cardiology services and patients presenting with adverse cardiovascular events during the pandemic.

Quitting smoking at the time of an Afib diagnosis could reduce risk of incident stroke event by 28%, according to a new analysis from ESC 2020.

Across racial and gender groups, CT scans that measure coronary artery calcium can more accurately predict the 10-year risk for heart attack.

Our latest case report from Dr. Brady Pregerson features a 72 y/o male with a history of hypertension and TIA. Check out the EKG and see if you can determine the diagnosis.

A meta-analysis of 4 randomized trials is shedding light on the efficacy and safety of direct oral anticoagulant use for reducing recurrent VTE in patients with cancer.

Director of Yale's Pulmonary Vascular Disease Program offers insight from a recent study he led attempting to determine the root cause of blood clots in COVID-19 patients.

A study from BCVS 2020 is shedding light on the potential cardiovascular benefits of receiving a seasonal influenza vaccination in patients at high risk for the flu.

Deepak Bhatt, MD, MPH, discusses the latest REDUCE-IT data presented at ASPC 2020 in an exclusive interview with Practical Cardiology.

S. Claiborne Johnston discusses the results of the phase 3 THALES trial examining use of ticagrelor dual antiplatelet therapy for reducing subsequent stroke in patients with AIS or TIA.

New research suggests IVC filter placement could attenuate the risk of pulmonary embolism in patients with cancer-related DVT.

A study from Vanderbilt University Medical Center details the apparent risks associated with bleeding and venous thromboembolism following noncardiac surgery.

Results of the phase 3 THALES trial detail the effect of ticagrelor DAPT for reducing the risk of stroke and death in patients with acute ischemic stroke or transient ischemic attack.

An analysis of the REGARDS study is shedding new light on the impact multiple social determinants of health can have on a patient's stroke risk.

Rates of recurrent stroke have been on the decline in recent years—reaching a rate similar to that of non-Hispanic whites by 2013.

Two major organizations have released a new statement outlining topics of research related to VTE in need of further research going forward.

An associate professor of medicine at Yale School of Medicine discusses the results of a study aimed at assessing the potential pathophysiology of COVID-19-associated blood clots.

New data from Mount Sinai Hospital suggests anticoagulant use could improve survival rates among patients hospitalized with COVID-19.

The AAN has released an update to their 2016 practice advisory—changing their stance on PFO closure to reduce risk of second stroke.

The Professor of Medicine at Duke University School of Medicine discusses prescribing DOACs and his opinion on a recent meta-analysis in the Annals of Internal Medicine.

Research from investigators at Brigham and Women's Hospital and Sinai Health is shedding new light on the differences in safety and efficacy between the 2 DOACs.

Analysis of more than 13k patients from Taiwan found a vegetarian diet was linked to a lower risk of incident stroke events later in life.

A fourth-year medical student discusses strategies for anticoagulation reversal in intensive care units from a presentation during the 49th Annual Critical Care Congress in Orlando.

A secondary analysis of patients with prior stroke, TIA, or thromboembolism from AUGUSTUS is revealing more about the use of apixaban in patients with AFib.

A study presented today at the 2020 International Stroke Conference in Los Angeles finds that the long-term use of low-dose aspirin in ischemic stroke patients who have a glucose-6-phosphate dehydrogenase (G6PD) deficiency, may have higher risks of moderate-to-severe bleeding and all-cause death.